Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 6, 2018Journal of Hematology & OncologyOpen Access

Control of triple-negative breast cancer using ex vivo self-enriched, costimulated NKG2D CAR T cells

View Full Paper
Ask AI
Bookmark
Share

Authors

YHYali HanShanghai Jiao Tong UniversityWXWei‐Fen XieState Council of the People's Republic of ChinaDSDe-Gang SongHebei Medical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Han et al. (2018) studied this question.

synapsesocial.com/papers/6a76143267b8a7e548707a82https://doi.org/10.1186/s13045-018-0635-z
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A T-cell–directed chimeric antigen receptor for the selective treatment of T-cell malignancies2015 · 342 citations
  2. 2Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level2016 · 141 citations
  3. 3T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia2011 · 2,434 citations
  4. 4Strain-dependent Lethal Toxicity in NKG2D Ligand-targeted CAR T-cell Therapy2015 · 17 citations
  5. 5Chimeric NKG2D CAR-Expressing T Cell-Mediated Attack of Human Ovarian Cancer Is Enhanced by Histone Deacetylase Inhibition2013 · 107 citations